🇰🇷 South Korea Country × Condition
solid tumors Clinical Trials in South Korea
Active clinical trials for solid tumors with research sites in South Korea. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 1, Phase 1, Phase 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇰🇷 South Korea
Active Trials in South Korea (2)
NCT05536141 Phase 1
Recruiting
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
Enrollment
362 pts
Country
🇰🇷 South Korea
Arcus Biosciences, Inc.
View Trial → NCT07158918 Phase 1, Phase 2
Recruiting
ABL103 in Combination With Pembrolizumab, With or Without Taxane in Advanced or Metastatic Solid Tumors
Enrollment
65 pts
Country
🇰🇷 South Korea
ABL Bio, Inc.
View Trial → Frequently Asked Questions
How many solid tumors clinical trials are active in South Korea?
There are currently 2 active clinical trials for solid tumors with sites in South Korea, of which 2 are actively recruiting patients.
How can I join a solid tumors clinical trial in South Korea?
To join a solid tumors clinical trial in South Korea, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in South Korea directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are solid tumors trials in South Korea?
Active solid tumors trials in South Korea span Phase 1, Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.